Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04215640

Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes

Paroxysmal Supraventricular Tachycardia Clinical Trial

Official title:
Radiofrequency Ablation of Paroxysmal Supraventricular Tachycardia Using a Novel Catheter Equipped With Mini Electrodes

Clinical Trial Summary

Paroxysmal supraventricular tachycardia is treated with radiofrequency ablation recently. This procedure is performed by ablating slow pathway or accessory pathway using radiofrequency ablation catheter. Recently developed mirofidelity (MIFI) catheter has mini-electrodes that can record local eletrogram with higher resolution. We aimed to investigate the efficacy of MIFI catheter in the ablation of paroxysmal supraventricular tachycardia compared to conventional radiofrequency ablation catheter. Enrolled patients undergo conventional electrophysiologic study. Patients with sustained supraventricular tachycardia during the study are randomized to either study group or control group. Radiofrequency ablation is performed using MIFI catheter in the study group, and conventional catheter (Blazer II) in the control group. The study endpoints are recorded immediately after ablation and there is no additional follow up or management after procedure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04215640
Study type Interventional
Source Seoul St. Mary's Hospital
Contact
Status Completed
Phase N/A
Start date January 13, 2020
Completion date November 1, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04072835 - Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303 Phase 3
Completed NCT01655316 - Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control Phase 4
Completed NCT05770921 - Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia（PSVT） N/A
Active, not recruiting NCT05820035 - A Multicenter Study of Pulsed Field Ablation for Paroxysmal Supraventricular Tachycardia N/A
Not yet recruiting NCT06327425 - MCG for Localization of Tachyarrhythmia's Origin N/A
Recruiting NCT05410860 - Efficacy and Safety Study of Etripamil Nasal Spray Self-Administration for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia Phase 3
Completed NCT03464019 - Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxymal Supraventricular Tachycardia (PSVT). NODE 301 [Part 1 and Part 2 (RAPID Study)] Phase 3
Completed NCT03042078 - Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia N/A
Completed NCT03348436 - Study on Left Atrial Function of Paroxysmal Supraventricular Tachycardia After Radiofrequency Ablation N/A
Enrolling by invitation NCT04952610 - Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia Phase 3
Recruiting NCT05763953 - The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) Phase 2
Terminated NCT03635996 - Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302 Phase 3